Johnson & Johnson Vaccine: Blood Clotting Circumstances Trigger Requires Pause in US
FDA certification of the Baltimore facility has now been delayed while inspectors investigate quality control issues and severely reduce the supply of Johnson & Johnson vaccines. The sudden drop in available doses sparked widespread…